Chemclin Diagnostics Co., Ltd. engages in the research and development, production, and sale of clinical immune chemiluminescence diagnostic testing reagents and instruments. Its products include LiCA series of diagnostic reagents based on photoinduced chemiluminescence method, and CC series diagnostic reagents and instruments based on enzymatic chemiluminescence method for primarily used in infectious diseases markers, tumor markers, thyroid hormones, reproduction detection of endocrine hormones, myocardial markers, and inflammation. The company was founded in 2007 and is based in Beijing, China.